Specify a stock or a cryptocurrency in the search bar to get a summary
Ningbo Menovo Pharm Co Ltd
603538Ningbo Menovo Pharmaceutical Co., Ltd. research, develops, produces, and sells pharmaceutical products. The company's products portfolio includes valsartan, losartan, clopidogrel, perindopril, rosuvastatin calcium, atorvastatin calcium, purin bahrain, and other products. It offers APIs, intermediates, and preparations for the treatment of cardiovascular, central nervous system, gastrointestinal tract, and other therapeutic areas. Ningbo Menovo Pharmaceutical Co., Ltd. was founded in 2004 and is headquartered in Ningbo, China. Address: Building1,Ningbo R&D Park, Ningbo, China, 315048
Analytics
WallStreet Target Price
152.3 CNYP/E ratio
175Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures 603538
Dividend Analytics 603538
Dividend growth over 5 years
28 %Continuous growth
–Payout Ratio 5 years average
84 %Dividend History 603538
Stock Valuation 603538
Financials 603538
Results | 2019 | Dynamics |